Sep 09, 2019 / 12:45PM GMT
David Ryan Lewis - Morgan Stanley, Research Division - MD
All right. Well, thanks for joining us here. My name is David Lewis, medical device analyst here at Morgan Stanley. This is our first presentation here at the Morgan Stanley Healthcare Conference 2019, so thanks to you all for joining us. It's my pleasure to have with us here the CEO of Shockwave, Doug Godshall.
And before I begin, obviously, I'll be saying this throughout the whole 3-day session. Make sure you go to the Morgan Stanley website and our research disclosures to see all kinds of fun facts about me.
But I'm going to start. Doug has agreed to dispense with the preamble, so we're going to drive right into it.
Questions and Answers:
David Ryan Lewis - Morgan Stanley, Research Division - MDBut Doug, obviously, Shockwave has brought to market this IVL technology. I think the interesting thing about this [dynamic, at least] for us when we started working with you is the -- where that technology can play. Maybe just quickly start up by just talking about -- there's a lot of
Trustpilot
